HRTX vs KLAC · rev $72.4M vs P/E 55, rev $13.58B
Heron Therapeuti (HRTX) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
HRTX currently screens at market cap $332.6M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the HRTX and KLAC stock pages for the full models.
Not investment advice.